Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C
- 1 May 2001
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 34 (5) , 748-755
- https://doi.org/10.1016/s0168-8278(01)00062-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon TherapyAnnals of Internal Medicine, 2000
- The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United StatesHepatology, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Chronic Hepatitis C and Interferon Alpha: Conventional and Cumulative Meta-Analyses of Randomized Controlled TrialsAmerican Journal of Gastroenterology, 1999
- Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic viewGastroenterology, 1999
- Combination Therapy for Hepatitis C InfectionNew England Journal of Medicine, 1998
- Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapyJournal of Medical Virology, 1998
- Correlation of biochemical response to interferon alfa with histological improvement in hepatitis C: A meta-analysis of diagnostic test characteristicsHepatology, 1997
- The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysisJournal of Hepatology, 1997
- Persistent Hepatitis C Viremia Predicts Late Relapse after Sustained Response to Interferon-α in Chronic Hepatitis CAnnals of Internal Medicine, 1996